The Biopharmaceutical Product Development Services program provides services to facilitate preclinical development of materials that are derived from biotechnology processes, such as monoclonal antibodies and derivatives of monoclonal antibodies;recombinant proteins;peptides;nucleic acid based vectors (siRNA, plasmids);and live, modified-live and/or attenuated entities. Services include: product development planning and evaluation;assay development and product release testing;process development and formulation;GMP manufacturing;and regulatory CMC documentation support.
